期刊文献+

^(153)Sm-EDTMP放射治疗辐射对肿瘤骨转移患者血象的影响 被引量:2

Effects of ^(153)Sm-EDTMP radiotherapy radiation on the blood of carcinoma bone metastases patient
下载PDF
导出
摘要 目的:探讨利用放射性制剂153Sm-EDTMP(153钐-乙二铵四甲基磷酸)对肿瘤骨转移疼痛患者进行治疗时,辐射对患者血象的影响。方法:利用全自动血液分析仪,对93例肿瘤骨转移疼痛患者153Sm-EDT-MP治疗前、治疗后1天、7天及1个月血象(包括红细胞、白细胞、血红蛋白、血小板等系列)进行检测并分析研究。结果:153Sm-EDTMP治疗后1天白细胞、粒细胞升高,淋巴细胞降低(P<0.05);治疗后7天白细胞、粒细胞、淋巴细胞、红细胞、血红蛋白测定及血小板计数均低于治疗前(P<0.05);治疗后1个月红细胞计数升高(P<0.05)。结论:利用153Sm-EDTMP治疗肿瘤骨转移疼痛时,辐射对患者血象有一定影响,但影响较轻微且为一过性,随时间推移,血象各项指标均可恢复正常。 Objective:To evaluate the effects of 153Sm-EDTMP radiotherapy radiation on the blood of carcinoma bone metastases patient.Methods:The level of blood(included red blood cell,white blood cell leukocyte,hemoglobin and platelet series) were measured by full automatic hemocyte analyzer in 93 cases of carcinoma bone metastases patient(before 153Sm-EDTMP radiotherapy,after 153Sm-EDTMP radiotherapy 1 day,7 days and 1 month).The changes of blood level were compared with that before 153Sm-EDTMP radiotherapy.Results:The level of leukocyte,granulocyte increased,lymphocyte decreased(P0.05) after 153Sm-EDTMP radiotherapy 1 day.The level of leukocyte,granulocyte,lymphocyte,red blood cell,hemoglobin and platelet decreased(P0.05) after 153Sm-EDTMP radiotherapy 7 days.The level of red blood cell increased after 153Sm-EDTMP radiotherapy 1 month(P0.05).Conclusion:Radiation of 153Sm-EDTMP radiotherapy on carcinoma bone metastases patients have influences on blood.The influence was light,the level of blood will be normal gradually.
出处 《现代肿瘤医学》 CAS 2010年第11期2248-2250,共3页 Journal of Modern Oncology
关键词 153SM-EDTMP 放射治疗 辐射 肿瘤 骨转移 血象 153Sm-EDTMP radiotherapy radiation carcinoma bone metastases blood
  • 相关文献

参考文献5

二级参考文献13

共引文献41

同被引文献42

  • 1要洁,张湘茹,朱继庆,罗扬.非小细胞肺癌骨转移的临床特点分析[J].实用癌症杂志,2004,19(4):392-395. 被引量:8
  • 2吴凡,吴健雄.结直肠癌骨转移的诊断与综合治疗[J].中国骨肿瘤骨病,2006,5(2):120-122. 被引量:4
  • 3Katoh M, Unakami M, Hara M, et al, Bone metastasis from colo- rectal cancer in autopsy cases[J]. J Gastroenterol, 1995,30(5): 615 618.
  • 4Kanthan R, Loewy J, Kanthan SC. Skeletal metastases in eolorec- tal carcinomas: a Saskatchewan profile [J]. Dis Colon Reetum, 1999,42(12) :1592-1597.
  • 5Sundermeyer ML, Meropol NJ, Rogatko A, et al. Changing pat- terns of bone and brain metastases in patients with eolorectal cancer[J]. Clin Colorectal Cancer,2005,5(2) : 108 113.
  • 6Santini D, Tampellini M, Vincenzi B, et al. Natural history of bone metastasis in colorectal cancer:final results o{ a large Italian bone me tastases study[J]. Ann Oncol,2012,23(8):2072-2077.
  • 7Roth ES, Fetzer DT, Barron BJ, et al. Does colon cancer ever me tastasize to bone first? a temporal analysis of colorectal cancer progression[J]. BMC Cancer, 2009,9 : 274.
  • 8Talbot J, Paycha F, Balogova S. Diagnosis of bone metastasis.- re- cent comparative studies o[ imaging modalities[J]. Q J Nucl Med Mol Imaging,2011,55(4) :374 410.
  • 9Balliu E, Boada M, Pelaez I, et al. Comparative study of whole- body MRI and bone scintigraphy for the detection of bone metas- tases[J]. Clin Radiol,2010,65(12) :989-996.
  • 10Gnant M, Balic M, Petru E, et al. Treatment of bone metastases in patients with advanced breast eancer[J]. Breast Care (Basel), 2012,7(2) :92 98.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部